KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Return on Assets: 2019-2024

Historic Return on Assets for Esperion Therapeutics (ESPR) over the last 6 years, with Dec 2024 value amounting to -0.02%.

  • Esperion Therapeutics' Return on Assets fell 18.00% to -0.30% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.30%, marking a year-over-year decrease of 18.00%. This contributed to the annual value of -0.02% for FY2024, which is 93.00% up from last year.
  • According to the latest figures from FY2024, Esperion Therapeutics' Return on Assets is -0.02%, which was up 98.13% from -0.95% recorded in FY2023.
  • In the past 5 years, Esperion Therapeutics' Return on Assets registered a high of -0.02% during FY2024, and its lowest value of -0.95% during FY2023.
  • Its 3-year average for Return on Assets is -0.57%, with a median of -0.75% in 2022.
  • As far as peak fluctuations go, Esperion Therapeutics' Return on Assets dropped by 24bps in 2021, and later soared by 93bps in 2024.
  • Esperion Therapeutics' Return on Assets (Yearly) stood at -0.51% in 2020, then fell by 24bps to -0.74% in 2021, then fell by 1bps to -0.75% in 2022, then declined by 19bps to -0.95% in 2023, then surged by 93bps to -0.02% in 2024.